MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Synergy Pharmaceuticals Company Profile (NASDAQ:SGYP)

Consensus Ratings for Synergy Pharmaceuticals (NASDAQ:SGYP) (?)
Ratings Breakdown: 1 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $11.93 (240.82% upside)

Analysts' Ratings History for Synergy Pharmaceuticals (NASDAQ:SGYP)
Show:
DateFirmActionRatingPrice TargetActions
5/26/2016Roth CapitalReiterated RatingBuy$6.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2016Rodman & RenshawReiterated RatingBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2016BTIG ResearchReiterated RatingBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2016Canaccord GenuityReiterated RatingBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2016Citigroup Inc.Lower Price TargetNeutral$7.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/1/2015HC WainwrightReiterated RatingBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015Cantor FitzgeraldReiterated RatingBuy$8.50 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/12/2014Cowen and CompanyInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/14/2014AegisLower Price Target$26.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha